nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—CES1—Capecitabine—kidney cancer	0.521	1	CbGbCtD
Trandolapril—ACE—renal artery—kidney cancer	0.0351	0.39	CbGeAlD
Trandolapril—ACE—nephron—kidney cancer	0.0123	0.137	CbGeAlD
Trandolapril—ACE—urine—kidney cancer	0.00985	0.109	CbGeAlD
Trandolapril—SLC15A1—nephron tubule—kidney cancer	0.0037	0.0411	CbGeAlD
Trandolapril—SLC15A1—renal system—kidney cancer	0.00336	0.0374	CbGeAlD
Trandolapril—SLC15A1—kidney—kidney cancer	0.00325	0.0361	CbGeAlD
Trandolapril—ACE—nephron tubule—kidney cancer	0.00265	0.0295	CbGeAlD
Trandolapril—ACE—Metabolism of Angiotensinogen to Angiotensins—MME—kidney cancer	0.00258	0.113	CbGpPWpGaD
Trandolapril—ACE—renal system—kidney cancer	0.00241	0.0268	CbGeAlD
Trandolapril—ACE—kidney—kidney cancer	0.00233	0.0259	CbGeAlD
Trandolapril—SLC15A2—nephron tubule—kidney cancer	0.00231	0.0257	CbGeAlD
Trandolapril—ACE—cortex of kidney—kidney cancer	0.00227	0.0252	CbGeAlD
Trandolapril—CES1—Fluoropyrimidine Activity—PPAT—kidney cancer	0.00218	0.0956	CbGpPWpGaD
Trandolapril—ACE—gonad—kidney cancer	0.00216	0.024	CbGeAlD
Trandolapril—ACE—cardiac atrium—kidney cancer	0.00216	0.024	CbGeAlD
Trandolapril—SLC15A2—renal system—kidney cancer	0.0021	0.0234	CbGeAlD
Trandolapril—SLC15A2—kidney—kidney cancer	0.00203	0.0226	CbGeAlD
Trandolapril—SLC15A2—cortex of kidney—kidney cancer	0.00198	0.022	CbGeAlD
Trandolapril—ACE—Metabolism of Angiotensinogen to Angiotensins—CTSD—kidney cancer	0.00187	0.082	CbGpPWpGaD
Trandolapril—CES1—Irinotecan Pathway—BCHE—kidney cancer	0.00175	0.0768	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—TFE3—kidney cancer	0.00121	0.0528	CbGpPWpGaD
Trandolapril—Perindopril—BCHE—kidney cancer	0.00116	0.282	CrCbGaD
Trandolapril—Ramipril—BCHE—kidney cancer	0.00099	0.241	CrCbGaD
Trandolapril—CES1—Irinotecan Pathway—APC—kidney cancer	0.000951	0.0417	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—MME—kidney cancer	0.000678	0.0297	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—APAF1—kidney cancer	0.000651	0.0285	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—ACHE—kidney cancer	0.00052	0.0228	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SLC5A3—kidney cancer	0.000503	0.022	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—PAX6—kidney cancer	0.000494	0.0217	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—CTSD—kidney cancer	0.000492	0.0216	CbGpPWpGaD
Trandolapril—Perindopril—ABCB1—kidney cancer	0.000454	0.111	CrCbGaD
Trandolapril—ACE—Peptide hormone metabolism—BCHE—kidney cancer	0.000453	0.0198	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—KEAP1—kidney cancer	0.00044	0.0193	CbGpPWpGaD
Trandolapril—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—kidney cancer	0.000434	0.019	CbGpPWpGaD
Trandolapril—Nateglinide—PTGS1—kidney cancer	0.000413	0.1	CrCbGaD
Trandolapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—kidney cancer	0.000402	0.0176	CbGpPWpGaD
Trandolapril—Lisinopril—ABCB1—kidney cancer	0.0004	0.0974	CrCbGaD
Trandolapril—Cilazapril—ABCB1—kidney cancer	0.0004	0.0974	CrCbGaD
Trandolapril—Enalapril—ABCB1—kidney cancer	0.000294	0.0715	CrCbGaD
Trandolapril—CES1—NRF2 pathway—SLC5A5—kidney cancer	0.000265	0.0116	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—EIF5B—kidney cancer	0.000259	0.0114	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—SLC2A1—kidney cancer	0.000256	0.0112	CbGpPWpGaD
Trandolapril—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—kidney cancer	0.000255	0.0112	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—EGR1—kidney cancer	0.000238	0.0104	CbGpPWpGaD
Trandolapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—kidney cancer	0.000237	0.0104	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—POMC—kidney cancer	0.000234	0.0102	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—CUL7—kidney cancer	0.000231	0.0101	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—HSPA9—kidney cancer	0.00022	0.00965	CbGpPWpGaD
Trandolapril—CES1—Fluoropyrimidine Activity—TP53—kidney cancer	0.000217	0.00949	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000216	0.00948	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GSTP1—kidney cancer	0.000214	0.00936	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—CDKN2A—kidney cancer	0.000206	0.00903	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000201	0.0088	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—GSTM1—kidney cancer	0.000196	0.0086	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000191	0.00839	CbGpPWpGaD
Trandolapril—CES1—E2F transcription factor network—CDKN1B—kidney cancer	0.000183	0.008	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—MUC4—kidney cancer	0.00018	0.00787	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000178	0.00778	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—ST3GAL2—kidney cancer	0.000171	0.00748	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—CTNNB1—kidney cancer	0.000167	0.00732	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—EEF2—kidney cancer	0.000167	0.00731	CbGpPWpGaD
Trandolapril—Mediastinal disorder—Capecitabine—kidney cancer	0.000142	0.000394	CcSEcCtD
Trandolapril—Anxiety—Paclitaxel—kidney cancer	0.000142	0.000393	CcSEcCtD
Trandolapril—Decreased appetite—Gemcitabine—kidney cancer	0.000142	0.000393	CcSEcCtD
Trandolapril—Hypersensitivity—Dactinomycin—kidney cancer	0.000142	0.000393	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000142	0.000392	CcSEcCtD
Trandolapril—Arrhythmia—Capecitabine—kidney cancer	0.000141	0.00039	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000141	0.00039	CcSEcCtD
Trandolapril—Discomfort—Paclitaxel—kidney cancer	0.000141	0.00039	CcSEcCtD
Trandolapril—Fatigue—Gemcitabine—kidney cancer	0.000141	0.00039	CcSEcCtD
Trandolapril—Gastrointestinal pain—Vincristine—kidney cancer	0.000141	0.000389	CcSEcCtD
Trandolapril—Cardiac arrest—Doxorubicin—kidney cancer	0.00014	0.000387	CcSEcCtD
Trandolapril—Dizziness—Sorafenib—kidney cancer	0.00014	0.000387	CcSEcCtD
Trandolapril—Constipation—Gemcitabine—kidney cancer	0.00014	0.000386	CcSEcCtD
Trandolapril—Nausea—Erlotinib—kidney cancer	0.00014	0.000386	CcSEcCtD
Trandolapril—CES1—E2F transcription factor network—MYC—kidney cancer	0.00014	0.00612	CbGpPWpGaD
Trandolapril—Alopecia—Capecitabine—kidney cancer	0.00014	0.000386	CcSEcCtD
Trandolapril—Dry mouth—Paclitaxel—kidney cancer	0.00014	0.000386	CcSEcCtD
Trandolapril—Diarrhoea—Sunitinib—kidney cancer	0.000139	0.000385	CcSEcCtD
Trandolapril—Mental disorder—Capecitabine—kidney cancer	0.000138	0.000383	CcSEcCtD
Trandolapril—Asthenia—Dactinomycin—kidney cancer	0.000138	0.000383	CcSEcCtD
Trandolapril—Blood creatinine increased—Doxorubicin—kidney cancer	0.000138	0.000381	CcSEcCtD
Trandolapril—Malnutrition—Capecitabine—kidney cancer	0.000138	0.00038	CcSEcCtD
Trandolapril—Oedema—Paclitaxel—kidney cancer	0.000137	0.000378	CcSEcCtD
Trandolapril—Abdominal pain—Vincristine—kidney cancer	0.000136	0.000377	CcSEcCtD
Trandolapril—Body temperature increased—Vincristine—kidney cancer	0.000136	0.000377	CcSEcCtD
Trandolapril—Liver function test abnormal—Doxorubicin—kidney cancer	0.000136	0.000376	CcSEcCtD
Trandolapril—Infection—Paclitaxel—kidney cancer	0.000136	0.000376	CcSEcCtD
Trandolapril—Flatulence—Capecitabine—kidney cancer	0.000136	0.000375	CcSEcCtD
Trandolapril—Dry skin—Doxorubicin—kidney cancer	0.000135	0.000373	CcSEcCtD
Trandolapril—Dysgeusia—Capecitabine—kidney cancer	0.000135	0.000373	CcSEcCtD
Trandolapril—Dizziness—Sunitinib—kidney cancer	0.000135	0.000372	CcSEcCtD
Trandolapril—Feeling abnormal—Gemcitabine—kidney cancer	0.000135	0.000372	CcSEcCtD
Trandolapril—Shock—Paclitaxel—kidney cancer	0.000135	0.000372	CcSEcCtD
Trandolapril—Vomiting—Sorafenib—kidney cancer	0.000135	0.000372	CcSEcCtD
Trandolapril—Nervous system disorder—Paclitaxel—kidney cancer	0.000134	0.000371	CcSEcCtD
Trandolapril—Thrombocytopenia—Paclitaxel—kidney cancer	0.000134	0.00037	CcSEcCtD
Trandolapril—Tachycardia—Paclitaxel—kidney cancer	0.000134	0.000369	CcSEcCtD
Trandolapril—Rash—Sorafenib—kidney cancer	0.000133	0.000369	CcSEcCtD
Trandolapril—Dermatitis—Sorafenib—kidney cancer	0.000133	0.000369	CcSEcCtD
Trandolapril—Back pain—Capecitabine—kidney cancer	0.000133	0.000368	CcSEcCtD
Trandolapril—Breast disorder—Doxorubicin—kidney cancer	0.000133	0.000368	CcSEcCtD
Trandolapril—Skin disorder—Paclitaxel—kidney cancer	0.000133	0.000367	CcSEcCtD
Trandolapril—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000133	0.000367	CcSEcCtD
Trandolapril—Headache—Sorafenib—kidney cancer	0.000133	0.000367	CcSEcCtD
Trandolapril—Muscle spasms—Capecitabine—kidney cancer	0.000132	0.000366	CcSEcCtD
Trandolapril—Hyperhidrosis—Paclitaxel—kidney cancer	0.000132	0.000366	CcSEcCtD
Trandolapril—Diarrhoea—Dactinomycin—kidney cancer	0.000132	0.000365	CcSEcCtD
Trandolapril—Anorexia—Paclitaxel—kidney cancer	0.00013	0.000361	CcSEcCtD
Trandolapril—Gastritis—Doxorubicin—kidney cancer	0.00013	0.00036	CcSEcCtD
Trandolapril—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.00013	0.000359	CcSEcCtD
Trandolapril—Vomiting—Sunitinib—kidney cancer	0.00013	0.000358	CcSEcCtD
Trandolapril—Body temperature increased—Gemcitabine—kidney cancer	0.000129	0.000357	CcSEcCtD
Trandolapril—Rash—Sunitinib—kidney cancer	0.000128	0.000355	CcSEcCtD
Trandolapril—Dermatitis—Sunitinib—kidney cancer	0.000128	0.000355	CcSEcCtD
Trandolapril—Abdominal distension—Doxorubicin—kidney cancer	0.000128	0.000354	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—MME—kidney cancer	0.000128	0.00561	CbGpPWpGaD
Trandolapril—Hypotension—Paclitaxel—kidney cancer	0.000128	0.000354	CcSEcCtD
Trandolapril—Ill-defined disorder—Capecitabine—kidney cancer	0.000128	0.000353	CcSEcCtD
Trandolapril—Headache—Sunitinib—kidney cancer	0.000128	0.000353	CcSEcCtD
Trandolapril—Anaemia—Capecitabine—kidney cancer	0.000127	0.000352	CcSEcCtD
Trandolapril—Hypersensitivity—Vincristine—kidney cancer	0.000127	0.000351	CcSEcCtD
Trandolapril—Eosinophilia—Doxorubicin—kidney cancer	0.000126	0.000348	CcSEcCtD
Trandolapril—Nausea—Sorafenib—kidney cancer	0.000126	0.000348	CcSEcCtD
Trandolapril—Pancreatitis—Doxorubicin—kidney cancer	0.000125	0.000345	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000125	0.000345	CcSEcCtD
Trandolapril—Malaise—Capecitabine—kidney cancer	0.000124	0.000343	CcSEcCtD
Trandolapril—Angina pectoris—Doxorubicin—kidney cancer	0.000124	0.000343	CcSEcCtD
Trandolapril—Insomnia—Paclitaxel—kidney cancer	0.000124	0.000342	CcSEcCtD
Trandolapril—Vertigo—Capecitabine—kidney cancer	0.000124	0.000342	CcSEcCtD
Trandolapril—Asthenia—Vincristine—kidney cancer	0.000124	0.000342	CcSEcCtD
Trandolapril—Syncope—Capecitabine—kidney cancer	0.000123	0.000341	CcSEcCtD
Trandolapril—Leukopenia—Capecitabine—kidney cancer	0.000123	0.000341	CcSEcCtD
Trandolapril—Paraesthesia—Paclitaxel—kidney cancer	0.000123	0.00034	CcSEcCtD
Trandolapril—Vomiting—Dactinomycin—kidney cancer	0.000123	0.000339	CcSEcCtD
Trandolapril—Bronchitis—Doxorubicin—kidney cancer	0.000122	0.000338	CcSEcCtD
Trandolapril—Dyspnoea—Paclitaxel—kidney cancer	0.000122	0.000337	CcSEcCtD
Trandolapril—Somnolence—Paclitaxel—kidney cancer	0.000122	0.000336	CcSEcCtD
Trandolapril—Palpitations—Capecitabine—kidney cancer	0.000122	0.000336	CcSEcCtD
Trandolapril—Rash—Dactinomycin—kidney cancer	0.000122	0.000336	CcSEcCtD
Trandolapril—Nausea—Sunitinib—kidney cancer	0.000121	0.000335	CcSEcCtD
Trandolapril—Loss of consciousness—Capecitabine—kidney cancer	0.000121	0.000334	CcSEcCtD
Trandolapril—Pancytopenia—Doxorubicin—kidney cancer	0.000121	0.000334	CcSEcCtD
Trandolapril—Dyspepsia—Paclitaxel—kidney cancer	0.00012	0.000333	CcSEcCtD
Trandolapril—Cough—Capecitabine—kidney cancer	0.00012	0.000332	CcSEcCtD
Trandolapril—Neutropenia—Doxorubicin—kidney cancer	0.000119	0.000329	CcSEcCtD
Trandolapril—Decreased appetite—Paclitaxel—kidney cancer	0.000119	0.000329	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—RPL14—kidney cancer	0.000119	0.00521	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—HSPD1—kidney cancer	0.000119	0.00521	CbGpPWpGaD
Trandolapril—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000118	0.000327	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000118	0.000327	CcSEcCtD
Trandolapril—Fatigue—Paclitaxel—kidney cancer	0.000118	0.000326	CcSEcCtD
Trandolapril—Diarrhoea—Vincristine—kidney cancer	0.000118	0.000326	CcSEcCtD
Trandolapril—Pollakiuria—Doxorubicin—kidney cancer	0.000118	0.000325	CcSEcCtD
Trandolapril—Asthenia—Gemcitabine—kidney cancer	0.000117	0.000324	CcSEcCtD
Trandolapril—Myalgia—Capecitabine—kidney cancer	0.000117	0.000324	CcSEcCtD
Trandolapril—Chest pain—Capecitabine—kidney cancer	0.000117	0.000324	CcSEcCtD
Trandolapril—Arthralgia—Capecitabine—kidney cancer	0.000117	0.000324	CcSEcCtD
Trandolapril—Constipation—Paclitaxel—kidney cancer	0.000117	0.000324	CcSEcCtD
Trandolapril—Anxiety—Capecitabine—kidney cancer	0.000117	0.000323	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000116	0.000322	CcSEcCtD
Trandolapril—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000116	0.000321	CcSEcCtD
Trandolapril—Discomfort—Capecitabine—kidney cancer	0.000116	0.00032	CcSEcCtD
Trandolapril—Pruritus—Gemcitabine—kidney cancer	0.000116	0.00032	CcSEcCtD
Trandolapril—Hyperglycaemia—Doxorubicin—kidney cancer	0.000115	0.000317	CcSEcCtD
Trandolapril—Dry mouth—Capecitabine—kidney cancer	0.000115	0.000317	CcSEcCtD
Trandolapril—Nausea—Dactinomycin—kidney cancer	0.000115	0.000317	CcSEcCtD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000114	0.005	CbGpPWpGaD
Trandolapril—Dizziness—Vincristine—kidney cancer	0.000114	0.000315	CcSEcCtD
Trandolapril—Drowsiness—Doxorubicin—kidney cancer	0.000113	0.000314	CcSEcCtD
Trandolapril—Infestation—Doxorubicin—kidney cancer	0.000113	0.000314	CcSEcCtD
Trandolapril—Infestation NOS—Doxorubicin—kidney cancer	0.000113	0.000314	CcSEcCtD
Trandolapril—Feeling abnormal—Paclitaxel—kidney cancer	0.000113	0.000312	CcSEcCtD
Trandolapril—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000113	0.000311	CcSEcCtD
Trandolapril—Oedema—Capecitabine—kidney cancer	0.000112	0.00031	CcSEcCtD
Trandolapril—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000112	0.000309	CcSEcCtD
Trandolapril—Diarrhoea—Gemcitabine—kidney cancer	0.000112	0.000309	CcSEcCtD
Trandolapril—Renal failure—Doxorubicin—kidney cancer	0.000112	0.000308	CcSEcCtD
Trandolapril—Infection—Capecitabine—kidney cancer	0.000112	0.000308	CcSEcCtD
Trandolapril—Shock—Capecitabine—kidney cancer	0.00011	0.000305	CcSEcCtD
Trandolapril—Urinary tract infection—Doxorubicin—kidney cancer	0.00011	0.000305	CcSEcCtD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.00011	0.00483	CbGpPWpGaD
Trandolapril—Nervous system disorder—Capecitabine—kidney cancer	0.00011	0.000304	CcSEcCtD
Trandolapril—Thrombocytopenia—Capecitabine—kidney cancer	0.00011	0.000304	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.00011	0.00482	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.00011	0.00482	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.00011	0.00482	CbGpPWpGaD
Trandolapril—Tachycardia—Capecitabine—kidney cancer	0.00011	0.000303	CcSEcCtD
Trandolapril—Vomiting—Vincristine—kidney cancer	0.00011	0.000303	CcSEcCtD
Trandolapril—Skin disorder—Capecitabine—kidney cancer	0.000109	0.000302	CcSEcCtD
Trandolapril—Sweating—Doxorubicin—kidney cancer	0.000109	0.000301	CcSEcCtD
Trandolapril—Urticaria—Paclitaxel—kidney cancer	0.000109	0.000301	CcSEcCtD
Trandolapril—Rash—Vincristine—kidney cancer	0.000109	0.0003	CcSEcCtD
Trandolapril—Hyperhidrosis—Capecitabine—kidney cancer	0.000109	0.0003	CcSEcCtD
Trandolapril—Dermatitis—Vincristine—kidney cancer	0.000109	0.0003	CcSEcCtD
Trandolapril—Body temperature increased—Paclitaxel—kidney cancer	0.000108	0.000299	CcSEcCtD
Trandolapril—Abdominal pain—Paclitaxel—kidney cancer	0.000108	0.000299	CcSEcCtD
Trandolapril—Headache—Vincristine—kidney cancer	0.000108	0.000298	CcSEcCtD
Trandolapril—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000107	0.000297	CcSEcCtD
Trandolapril—Epistaxis—Doxorubicin—kidney cancer	0.000107	0.000296	CcSEcCtD
Trandolapril—Anorexia—Capecitabine—kidney cancer	0.000107	0.000296	CcSEcCtD
Trandolapril—Agranulocytosis—Doxorubicin—kidney cancer	0.000106	0.000293	CcSEcCtD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000106	0.00464	CbGpPWpGaD
Trandolapril—Hypotension—Capecitabine—kidney cancer	0.000105	0.00029	CcSEcCtD
Trandolapril—Vomiting—Gemcitabine—kidney cancer	0.000104	0.000287	CcSEcCtD
Trandolapril—Bradycardia—Doxorubicin—kidney cancer	0.000104	0.000287	CcSEcCtD
Trandolapril—Rash—Gemcitabine—kidney cancer	0.000103	0.000285	CcSEcCtD
Trandolapril—Dermatitis—Gemcitabine—kidney cancer	0.000103	0.000285	CcSEcCtD
Trandolapril—Headache—Gemcitabine—kidney cancer	0.000102	0.000283	CcSEcCtD
Trandolapril—Nausea—Vincristine—kidney cancer	0.000102	0.000283	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000102	0.000283	CcSEcCtD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000102	0.00448	CbGpPWpGaD
Trandolapril—Rhinitis—Doxorubicin—kidney cancer	0.000102	0.000282	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000102	0.00447	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000102	0.00447	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000102	0.00447	CbGpPWpGaD
Trandolapril—Hepatitis—Doxorubicin—kidney cancer	0.000102	0.000282	CcSEcCtD
Trandolapril—Insomnia—Capecitabine—kidney cancer	0.000102	0.000281	CcSEcCtD
Trandolapril—Pharyngitis—Doxorubicin—kidney cancer	0.000101	0.00028	CcSEcCtD
Trandolapril—Paraesthesia—Capecitabine—kidney cancer	0.000101	0.000279	CcSEcCtD
Trandolapril—Hypersensitivity—Paclitaxel—kidney cancer	0.000101	0.000279	CcSEcCtD
Trandolapril—Urinary tract disorder—Doxorubicin—kidney cancer	0.000101	0.000278	CcSEcCtD
Trandolapril—Oedema peripheral—Doxorubicin—kidney cancer	0.0001	0.000277	CcSEcCtD
Trandolapril—Connective tissue disorder—Doxorubicin—kidney cancer	0.0001	0.000277	CcSEcCtD
Trandolapril—Dyspnoea—Capecitabine—kidney cancer	0.0001	0.000277	CcSEcCtD
Trandolapril—Urethral disorder—Doxorubicin—kidney cancer	9.99e-05	0.000276	CcSEcCtD
Trandolapril—Dyspepsia—Capecitabine—kidney cancer	9.89e-05	0.000273	CcSEcCtD
Trandolapril—Visual impairment—Doxorubicin—kidney cancer	9.82e-05	0.000271	CcSEcCtD
Trandolapril—Asthenia—Paclitaxel—kidney cancer	9.82e-05	0.000271	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—ACHE—kidney cancer	9.81e-05	0.0043	CbGpPWpGaD
Trandolapril—Decreased appetite—Capecitabine—kidney cancer	9.76e-05	0.00027	CcSEcCtD
Trandolapril—Nausea—Gemcitabine—kidney cancer	9.71e-05	0.000268	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—EIF4EBP1—kidney cancer	9.7e-05	0.00425	CbGpPWpGaD
Trandolapril—Gastrointestinal disorder—Capecitabine—kidney cancer	9.7e-05	0.000268	CcSEcCtD
Trandolapril—Fatigue—Capecitabine—kidney cancer	9.68e-05	0.000268	CcSEcCtD
Trandolapril—Pruritus—Paclitaxel—kidney cancer	9.68e-05	0.000268	CcSEcCtD
Trandolapril—Erythema multiforme—Doxorubicin—kidney cancer	9.63e-05	0.000266	CcSEcCtD
Trandolapril—Constipation—Capecitabine—kidney cancer	9.6e-05	0.000265	CcSEcCtD
Trandolapril—Eye disorder—Doxorubicin—kidney cancer	9.52e-05	0.000263	CcSEcCtD
Trandolapril—Tinnitus—Doxorubicin—kidney cancer	9.5e-05	0.000263	CcSEcCtD
Trandolapril—Cardiac disorder—Doxorubicin—kidney cancer	9.46e-05	0.000261	CcSEcCtD
Trandolapril—Flushing—Doxorubicin—kidney cancer	9.46e-05	0.000261	CcSEcCtD
Trandolapril—Diarrhoea—Paclitaxel—kidney cancer	9.36e-05	0.000259	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—PAX6—kidney cancer	9.33e-05	0.00409	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—CTSD—kidney cancer	9.29e-05	0.00407	CbGpPWpGaD
Trandolapril—Feeling abnormal—Capecitabine—kidney cancer	9.25e-05	0.000256	CcSEcCtD
Trandolapril—Angiopathy—Doxorubicin—kidney cancer	9.24e-05	0.000256	CcSEcCtD
Trandolapril—Immune system disorder—Doxorubicin—kidney cancer	9.2e-05	0.000254	CcSEcCtD
Trandolapril—Gastrointestinal pain—Capecitabine—kidney cancer	9.18e-05	0.000254	CcSEcCtD
Trandolapril—Mediastinal disorder—Doxorubicin—kidney cancer	9.18e-05	0.000254	CcSEcCtD
Trandolapril—Arrhythmia—Doxorubicin—kidney cancer	9.1e-05	0.000252	CcSEcCtD
Trandolapril—Dizziness—Paclitaxel—kidney cancer	9.05e-05	0.00025	CcSEcCtD
Trandolapril—Alopecia—Doxorubicin—kidney cancer	9e-05	0.000249	CcSEcCtD
Trandolapril—Mental disorder—Doxorubicin—kidney cancer	8.93e-05	0.000247	CcSEcCtD
Trandolapril—Urticaria—Capecitabine—kidney cancer	8.92e-05	0.000247	CcSEcCtD
Trandolapril—Abdominal pain—Capecitabine—kidney cancer	8.88e-05	0.000245	CcSEcCtD
Trandolapril—Body temperature increased—Capecitabine—kidney cancer	8.88e-05	0.000245	CcSEcCtD
Trandolapril—Malnutrition—Doxorubicin—kidney cancer	8.87e-05	0.000245	CcSEcCtD
Trandolapril—Flatulence—Doxorubicin—kidney cancer	8.74e-05	0.000242	CcSEcCtD
Trandolapril—Vomiting—Paclitaxel—kidney cancer	8.7e-05	0.000241	CcSEcCtD
Trandolapril—Dysgeusia—Doxorubicin—kidney cancer	8.69e-05	0.00024	CcSEcCtD
Trandolapril—Rash—Paclitaxel—kidney cancer	8.63e-05	0.000239	CcSEcCtD
Trandolapril—Dermatitis—Paclitaxel—kidney cancer	8.62e-05	0.000238	CcSEcCtD
Trandolapril—Back pain—Doxorubicin—kidney cancer	8.58e-05	0.000237	CcSEcCtD
Trandolapril—Headache—Paclitaxel—kidney cancer	8.57e-05	0.000237	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—BCHE—kidney cancer	8.55e-05	0.00374	CbGpPWpGaD
Trandolapril—Muscle spasms—Doxorubicin—kidney cancer	8.53e-05	0.000236	CcSEcCtD
Trandolapril—Hypersensitivity—Capecitabine—kidney cancer	8.27e-05	0.000229	CcSEcCtD
Trandolapril—Ill-defined disorder—Doxorubicin—kidney cancer	8.23e-05	0.000228	CcSEcCtD
Trandolapril—Anaemia—Doxorubicin—kidney cancer	8.2e-05	0.000227	CcSEcCtD
Trandolapril—Agitation—Doxorubicin—kidney cancer	8.15e-05	0.000225	CcSEcCtD
Trandolapril—Nausea—Paclitaxel—kidney cancer	8.13e-05	0.000225	CcSEcCtD
Trandolapril—Asthenia—Capecitabine—kidney cancer	8.06e-05	0.000223	CcSEcCtD
Trandolapril—Malaise—Doxorubicin—kidney cancer	8e-05	0.000221	CcSEcCtD
Trandolapril—Vertigo—Doxorubicin—kidney cancer	7.97e-05	0.00022	CcSEcCtD
Trandolapril—Syncope—Doxorubicin—kidney cancer	7.95e-05	0.00022	CcSEcCtD
Trandolapril—Pruritus—Capecitabine—kidney cancer	7.95e-05	0.00022	CcSEcCtD
Trandolapril—Leukopenia—Doxorubicin—kidney cancer	7.94e-05	0.000219	CcSEcCtD
Trandolapril—Palpitations—Doxorubicin—kidney cancer	7.84e-05	0.000217	CcSEcCtD
Trandolapril—Loss of consciousness—Doxorubicin—kidney cancer	7.8e-05	0.000216	CcSEcCtD
Trandolapril—Cough—Doxorubicin—kidney cancer	7.74e-05	0.000214	CcSEcCtD
Trandolapril—Diarrhoea—Capecitabine—kidney cancer	7.68e-05	0.000212	CcSEcCtD
Trandolapril—Arthralgia—Doxorubicin—kidney cancer	7.55e-05	0.000209	CcSEcCtD
Trandolapril—Myalgia—Doxorubicin—kidney cancer	7.55e-05	0.000209	CcSEcCtD
Trandolapril—Chest pain—Doxorubicin—kidney cancer	7.55e-05	0.000209	CcSEcCtD
Trandolapril—Anxiety—Doxorubicin—kidney cancer	7.53e-05	0.000208	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	7.5e-05	0.000207	CcSEcCtD
Trandolapril—Discomfort—Doxorubicin—kidney cancer	7.46e-05	0.000206	CcSEcCtD
Trandolapril—Dizziness—Capecitabine—kidney cancer	7.43e-05	0.000205	CcSEcCtD
Trandolapril—Dry mouth—Doxorubicin—kidney cancer	7.39e-05	0.000204	CcSEcCtD
Trandolapril—Oedema—Doxorubicin—kidney cancer	7.24e-05	0.0002	CcSEcCtD
Trandolapril—Infection—Doxorubicin—kidney cancer	7.19e-05	0.000199	CcSEcCtD
Trandolapril—Vomiting—Capecitabine—kidney cancer	7.14e-05	0.000197	CcSEcCtD
Trandolapril—Shock—Doxorubicin—kidney cancer	7.12e-05	0.000197	CcSEcCtD
Trandolapril—Nervous system disorder—Doxorubicin—kidney cancer	7.1e-05	0.000196	CcSEcCtD
Trandolapril—Thrombocytopenia—Doxorubicin—kidney cancer	7.09e-05	0.000196	CcSEcCtD
Trandolapril—Rash—Capecitabine—kidney cancer	7.08e-05	0.000196	CcSEcCtD
Trandolapril—Dermatitis—Capecitabine—kidney cancer	7.07e-05	0.000196	CcSEcCtD
Trandolapril—Tachycardia—Doxorubicin—kidney cancer	7.06e-05	0.000195	CcSEcCtD
Trandolapril—Headache—Capecitabine—kidney cancer	7.04e-05	0.000194	CcSEcCtD
Trandolapril—Skin disorder—Doxorubicin—kidney cancer	7.03e-05	0.000194	CcSEcCtD
Trandolapril—Hyperhidrosis—Doxorubicin—kidney cancer	7e-05	0.000193	CcSEcCtD
Trandolapril—Anorexia—Doxorubicin—kidney cancer	6.9e-05	0.000191	CcSEcCtD
Trandolapril—Hypotension—Doxorubicin—kidney cancer	6.76e-05	0.000187	CcSEcCtD
Trandolapril—Nausea—Capecitabine—kidney cancer	6.67e-05	0.000184	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—IGF2—kidney cancer	6.62e-05	0.0029	CbGpPWpGaD
Trandolapril—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.6e-05	0.000182	CcSEcCtD
Trandolapril—Insomnia—Doxorubicin—kidney cancer	6.55e-05	0.000181	CcSEcCtD
Trandolapril—Paraesthesia—Doxorubicin—kidney cancer	6.5e-05	0.00018	CcSEcCtD
Trandolapril—Dyspnoea—Doxorubicin—kidney cancer	6.45e-05	0.000178	CcSEcCtD
Trandolapril—Somnolence—Doxorubicin—kidney cancer	6.44e-05	0.000178	CcSEcCtD
Trandolapril—Dyspepsia—Doxorubicin—kidney cancer	6.37e-05	0.000176	CcSEcCtD
Trandolapril—Decreased appetite—Doxorubicin—kidney cancer	6.29e-05	0.000174	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Doxorubicin—kidney cancer	6.25e-05	0.000173	CcSEcCtD
Trandolapril—Fatigue—Doxorubicin—kidney cancer	6.24e-05	0.000173	CcSEcCtD
Trandolapril—Constipation—Doxorubicin—kidney cancer	6.19e-05	0.000171	CcSEcCtD
Trandolapril—Feeling abnormal—Doxorubicin—kidney cancer	5.97e-05	0.000165	CcSEcCtD
Trandolapril—Gastrointestinal pain—Doxorubicin—kidney cancer	5.92e-05	0.000164	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5.8e-05	0.00254	CbGpPWpGaD
Trandolapril—Urticaria—Doxorubicin—kidney cancer	5.75e-05	0.000159	CcSEcCtD
Trandolapril—Abdominal pain—Doxorubicin—kidney cancer	5.72e-05	0.000158	CcSEcCtD
Trandolapril—Body temperature increased—Doxorubicin—kidney cancer	5.72e-05	0.000158	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.6e-05	0.00245	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5.38e-05	0.00236	CbGpPWpGaD
Trandolapril—Hypersensitivity—Doxorubicin—kidney cancer	5.33e-05	0.000147	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.2e-05	0.00228	CbGpPWpGaD
Trandolapril—Asthenia—Doxorubicin—kidney cancer	5.19e-05	0.000144	CcSEcCtD
Trandolapril—Pruritus—Doxorubicin—kidney cancer	5.12e-05	0.000142	CcSEcCtD
Trandolapril—Diarrhoea—Doxorubicin—kidney cancer	4.95e-05	0.000137	CcSEcCtD
Trandolapril—Dizziness—Doxorubicin—kidney cancer	4.79e-05	0.000132	CcSEcCtD
Trandolapril—Vomiting—Doxorubicin—kidney cancer	4.6e-05	0.000127	CcSEcCtD
Trandolapril—Rash—Doxorubicin—kidney cancer	4.56e-05	0.000126	CcSEcCtD
Trandolapril—Dermatitis—Doxorubicin—kidney cancer	4.56e-05	0.000126	CcSEcCtD
Trandolapril—Headache—Doxorubicin—kidney cancer	4.53e-05	0.000125	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.42e-05	0.00194	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—POMC—kidney cancer	4.42e-05	0.00194	CbGpPWpGaD
Trandolapril—Nausea—Doxorubicin—kidney cancer	4.3e-05	0.000119	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.1e-05	0.0018	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—CTNNB1—kidney cancer	3.15e-05	0.00138	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.5e-05	0.0011	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.32e-05	0.00102	CbGpPWpGaD
